NINA Capital Buys 25,000 PETMED Shares Amid Insider Buying Surge—Is a Comeback on the Horizon?
Investors eye PETMED EXPRESS after NINA Capital’s $1.75 buy – a small premium on a steeply down 54% stock, signaling cautious optimism amid insider buying and potential retail‑pharmacy revival.
2 minutes to read